Farxiga 10 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F91XD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $103,594
Award facts
- Contract value 100% obligated
- $103,594.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $103,594.13 to AmerisourceBergen Drug Corp for the supply of FARXIGA 10 mg tablets (30-count units) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price delivery order utilizes no set-aside designation and represents a task order executed under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00 and extending through December 2031, serves as the primary vehicle for delivering comprehensive pharmaceutical and medical supply support to military healthcare programs globally, including medications across multiple therapeutic domains.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that supplies critical medical products to federal defense and healthcare systems. FARXIGA (dapagliflozin) is a diabetes medication commonly used in military treatment facilities and veterans' healthcare programs. The delivery order will be fulfilled at the company's Conshohocken location, consistent with AmerisourceBergen's established role as a key vendor in the federal medical supply chain. This award demonstrates the contractor's continued capacity to meet competitive federal procurement requirements for essential pharmaceutical commodities supporting Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F91XD?
SPE2DR26F91XD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F91XD worth?
The government has obligated $103,594 on SPE2DR26F91XD.
Is contract SPE2DR26F91XD an order under another contract?
Yes. SPE2DR26F91XD is a delivery order under SPE2DR25D2103, an indefinite delivery contract.
Was contract SPE2DR26F91XD competed?
The extent of competition for SPE2DR26F91XD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award